Skip to main content
Photo: verobeachneurology.com

Vero Beach Neurology and Research Institute

Vero Beach, Florida

Regional Neurology Group
5 Active TrialsInfusion CenterEst. 2016Small Practice
27 MS centers statewide · Ranked #6 in Florida for clinical trials

At a glance

Infusion on site
Yes
Clinical trials
5 active

What kind of place is this?

AI summary of this centre's website
Comprehensive Care TeamResearch Focused

You’ll find a small, specialized neurology and MS center where your care can feel personal and focused. You may appreciate the mix of treatment options, onsite infusions, diagnostic testing, support groups, and access to clinical research.

Facility Profile

Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access4/5
Support Services4/5
Clinical Trials & Research4/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care2/5

About Vero Beach Neurology and Research Institute

AI summary of this centre's website
This center combines MS care with active research, including a dedicated clinical trials program and an onsite infusion center. It also offers second opinion visits for patients who want another expert look at their care.

Vero Beach Neurology and Research Institute serves people living with multiple sclerosis, including primary progressive, relapsing-remitting, and secondary progressive forms. You can also come here for initial visits, second opinions, diagnostic testing, IV therapies, and support groups. The center has an onsite infusion setup and participates in clinical research through a partnership with Geodyssey Research. Its team also treats a broad range of other neurological conditions, which can be helpful if your symptoms need a wider workup.

Vero Beach Neurology and Research Institute is an MS center in Vero Beach that combines neurology care with research in a small, focused setting. You can get evaluated, treated, and followed by a team that offers infusion therapy, diagnostic testing, support groups, and clinical research. The center also cares for people with related neurological conditions such as migraine, Parkinson's disease, epilepsy, and neuropathy.

Featured Care Team Members

S. James Shafer, MD
Principal Investigator; Medical Director
Adult Neurology; Multiple Sclerosis
Stacy Smith, PA-C
Sub-investigator and Examining Investigator
Multiple Sclerosis
Bryon Wiley
Examining Investigator
Electroneurodiagnostics

Partnerships & Referral Network

  • Geodyssey Research (clinical trials partnership)

Services & Treatments

What They Treat

Multiple SclerosisPrimary Progressive Multiple SclerosisRelapsing-Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosisdementiacognitive disordersepilepsymigraineParkinson's diseasemovement disordersstrokecerebrovascular diseasemyasthenia gravisneuromyelitis opticamyositisinflammatory neuropathiesGuillain-Barré syndromeperipheral neuropathyCIDPfibromyalgiavestibular disordersnormal pressure hydrocephalusALSbrain tumors

How They Treat It

acute headache managementdiagnostic servicesinitial consultationssecond opinion consultationsIV therapiessupport groupsclinical researchIVIgTysabriOcrevusSolumedrolBotox injectionsover-the-counter medicationsimmune suppressing medicationsimmune modifying medications

Diagnostics

MRIevoked potential testinglumbar punctureblood testingVERSSEPNCVEMGEEGBAER

Research & Clinical Trials

This center is currently involved in 5 clinical trials

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
Closed to new patientsPhase 3
Ocrelizumab
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Closed to new patientsPhase 3
OcrelizumabPlacebo
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
RecruitingPhase 3
Remibrutinib oral treatmentOcrelizumab
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Closed to new patientsPhase 3
RemibrutinibTeriflunomide
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Closed to new patientsPhase 3
Ofatumumab approved doseOfatumumab new dose

Insurance & Access

Contact

1040 37th Pl Suite 201, Vero Beach, FL 32960

Insurance & Support

Support Groups

FAQs from Vero Beach Neurology and Research Institute

You can get initial consultations, second opinion visits, diagnostic services, IV therapies, support groups, and clinical research. The center treats multiple sclerosis, including primary progressive, relapsing-remitting, and secondary progressive MS.

The center offers IVIg, Tysabri, Ocrevus, and Solumedrol as MS infusions. Infusion care is provided onsite.

Testing options include MRI, evoked potential testing, lumbar puncture, blood testing, VER, SSEP, NCVEMG, EEG, and BAER. These tests can help evaluate MS and other neurological conditions.

Yes. The center has a clinical research program and lists 4 active clinical trials. It also works with Geodyssey Research.

Yes, both are available. The center offers second opinion consultations and general support groups for patients.

MS Centers Across the U.S.

Click a state to browse its MS treatment centers.

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play
Call Website